Sagimet Biosciences Inc. (SGMT) earnings
SGMT earnings moved a median of -0.52% by the close. Quarterly and annual SGMT reports and results, each read against the price at its own news timestamp. Back to the SGMT overview →
21 measured SGMT earnings events.
Where these SGMT earnings landedvs 19 measured SGMT earnings reactions
| Middle 50% of SGMT earnings reactions | -8.86% to +0.68% |
|---|---|
| Median reaction (to close) | -0.52% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 SGMT earnings events with a measured close landed between -8.86% and +0.68%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Sagimet Biosciences Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.61% | -0.52% | |
| Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates | Press release | +2.61% | -0.52% | |
| Form 10-Q Sagimet Biosciences Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.20% | +0.79% | |
| Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | Press release | +0.20% | +0.79% | |
| Form 10-K Sagimet Biosciences Inc. For: Dec 31 | SEC filing · Form 10-K | +2.89% | -0.52% | |
| Form 10-Q Sagimet Biosciences Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.02% | — | |
| Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates | Press release | -3.02% | — | |
| Form 10-Q Sagimet Biosciences Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.04% | -0.52% | |
| Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates | Press release | +1.04% | -0.52% | |
| Form 10-Q Sagimet Biosciences Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.04% | -7.25% | |
| Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates | Press release | -0.04% | -7.25% | |
| Form 10-K Sagimet Biosciences Inc. For: Dec 31 | SEC filing · Form 10-K | -1.15% | +0.57% | |
| Form 10-Q Sagimet Biosciences Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.02% | -12.20% | |
| Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | Press release | -2.02% | -12.20% | |
| Form 10-Q Sagimet Biosciences Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.58% | -8.86% | |
| Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates | Press release | +2.58% | -8.86% | |
| Form 10-Q Sagimet Biosciences Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.42% | +4.76% | |
| Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates | Press release | +4.42% | +4.76% | |
| Form 10-K Sagimet Biosciences Inc. For: Dec 31 | SEC filing · Form 10-K | +7.48% | +8.52% | |
| Form 10-Q Sagimet Biosciences Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.87% | -20.07% | |
| Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates | Press release | -2.87% | -20.07% |
Keep exploring
More SGMT: analyst actions → · SEC filings → · SGMT overview →